Literature DB >> 12391277

Signaling pathway from the human adenosine A(3) receptor expressed in Chinese hamster ovary cells to the extracellular signal-regulated kinase 1/2.

Gunnar Schulte1, Bertil B Fredholm.   

Abstract

Adenosine activates four different receptors, the A(1), A(2A), A(2B), and the A(3) receptors, all of which are G protein-coupled. We have previously shown that stimulation of the human adenosine A(3) receptor can induce phosphorylation of extracellular signal-regulated kinase (ERK1/2). Here we show that the adenosine receptor agonist 5' N-ethylcarboxamidoadenosine (NECA) induces phosphorylation and activation of ERK1/2 in Chinese hamster ovary (CHO) cells expressing the human adenosine A(3) receptor (CHO A(3) cells) with the same potency. Pretreatment with pertussis toxin abolished the effect, which also could be blunted by overexpressing the betagamma-sequestering peptide beta-adrenergic receptor kinase-ct, implicating the involvement of betagamma subunits released from G(i/o) proteins. Activation of phosphatidylinositol-3-kinase (PI3K) by adenosine A(3) receptors is inferred from a dose-dependent Ser-phosphorylation of the protein kinase B (Akt). Furthermore the ERK1/2 phosphorylation was sensitive to the PI3K inhibitors wortmannin and LY294002 (2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride) and the MEK inhibitor PD98059 (2'-amino-3'-methoxyflavone), whereas chelation of Ca(2+) with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetrakis (acetoxymethyl ester) and long-term treatment with phorboldibutyrate did not decrease the adenosine A(3) receptor-mediated ERK1/2 phosphorylation. Thus, Ca(2+) mobilization and conventional and novel protein kinase C (PKC) isoforms are not involved in this pathway. The atypical PKCzeta was not activated by NECA and thus not involved in the A(3) receptor-mediated ERK1/2 phosphorylation. NECA stimulation of CHO A(3) cells activated the small G protein Ras and the dominant negative mutant RasS17N prevented the phosphorylation of ERK1/2. In conclusion, the adenosine A(3) receptor recruits a pathway that involves betagamma release from G(i/o), PI3K, Ras, and MEK to induce ERK1/2 phosphorylation and activation, whereas signaling is independent of Ca(2+), PKC, and c-Src.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391277     DOI: 10.1124/mol.62.5.1137

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  22 in total

1.  Testicular expression of Adora3i2 in Adora3 knockout mice reveals a role of mouse A3Ri2 and human A3Ri3 adenosine receptors in sperm.

Authors:  Lindsey A Burnett; Edik M Blais; Jashvant D Unadkat; Bertil Hille; Stephen L Tilley; Donner F Babcock
Journal:  J Biol Chem       Date:  2010-08-23       Impact factor: 5.157

Review 2.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

3.  Suppressive roles of A3AR and TMIGD3 i1 in osteosarcoma malignancy.

Authors:  Atul Ranjan; Swathi V Iyer; Tomoo Iwakuma
Journal:  Cell Cycle       Date:  2017-03-29       Impact factor: 4.534

4.  Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity.

Authors:  Sarvesh Jajoo; Debashree Mukherjea; Kounosuke Watabe; Vickram Ramkumar
Journal:  Neoplasia       Date:  2009-11       Impact factor: 5.715

5.  Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.

Authors:  Petr Mlejnek; Petr Dolezel; Ivo Frydrych
Journal:  J Physiol Biochem       Date:  2012-11-27       Impact factor: 4.158

6.  A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs.

Authors:  John A Auchampach; Zhe-Dong Ge; Tina C Wan; Jeannine Moore; Garrett J Gross
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-04-10       Impact factor: 4.733

Review 7.  G protein coupled receptors signaling pathways implicate in inflammatory and immune response of rheumatoid arthritis.

Authors:  Jinling Shu; Feng Zhang; Lingling Zhang; Wei Wei
Journal:  Inflamm Res       Date:  2016-11-23       Impact factor: 4.575

8.  Antagonist selective modulation of adenosine A1 and A3 receptor pharmacology by the food dye Brilliant Black BN: evidence for allosteric interactions.

Authors:  L T May; S J Briddon; S J Hill
Journal:  Mol Pharmacol       Date:  2010-01-19       Impact factor: 4.436

9.  Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 Receptor.

Authors:  Jo-Anne Baltos; Silvia Paoletta; Anh T N Nguyen; Karen J Gregory; Dilip K Tosh; Arthur Christopoulos; Kenneth A Jacobson; Lauren T May
Journal:  Mol Pharmacol       Date:  2016-05-02       Impact factor: 4.436

Review 10.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.